Regulation of Cranial Suture Development by TGF-Beta and Fibroblast Growth Factor

TGF-β 和成纤维细胞生长因子对颅缝发育的调节

基本信息

  • 批准号:
    7224143
  • 负责人:
  • 金额:
    $ 13.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-05-10 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Craniosynostosis is a significant health issue in humans, yet the pathogenesis and the mechanism of craniosynostosis are still unsolved. Clinical and experimental studies have implicated Transforming Growth Factor-a 1 (TGF-beta1) and Fibroblast Growth Factor-2 in cranial suture fusion. There is evidence that the effect of one or both molecules on suture fusion may be further altered by noggin, a bone morphogenetic protein antagonist. Gain of function mutations in FGF receptors have been reported in numerous human craniosynostosis syndromes, with the majority of these syndromes implicating FGF receptors 2 (FGFR2). However, the precise role of TGF-beta1 and FGF-2 in cranial suture development has not been explained. We hypothesize that 1) during the period of posterior frontal (PF) suture development in the mouse, altered biologic activity of TGF-beta1 and FGF-2 regulates fusion of the overlying suture calvaria, and 2) expression of these molecules in the fused PF suture in mice parallels that in fused sutures from human children with congenital craniosynostosis. Alteration in FGFR2 and noggin may also contribute to alter biologic activity of TGF-Beta1 and FGF-2 and further regulate suture fusion. Specific aims are 1) To quantity gene expression of TGF-beta1, FGF-2, FGFR2, and noggin in mouse cranial tissues harvested from both in vivo and in vitro models. Additionally, protein levels of TGF- beta1, FDF-2, and noggin will be measured in culture media in vitro using ELISA. 2) To quantitate gene expression of these same growth factors and receptors harvested from human patients with cogenital craniosynostosis. We will harvest tissue from both a fused suture and a patent suture from children undergoing craniotomy as part of the standard treatment for craniosynotosis. These data will be used to help determine the relationship between the mouse and human cranial suture systems. 3) To modulate cranial suture fusion in the mouse model, in vitro by modulating the bioavailability of the growth factor and receptors described in Aim 1. We will add recombinant forms of each molecule or antibodies to these molecules to either induce fusion of the normally patent sagittal suture or block the normal fusion of the PF suture. 4) To investigate the possibility of in vitro plasmid DNA transfection of mouse cranial tissue. If successful, gene manipulation of the target growth factors and receptors may be used to regulate cranial suture development in future studies. 5) To gain adequate knowledge of molecular biology to develop into an independent clinician-scientist. This proposal will provide mechanistic insights into the regulation of cranial suture development, and help to relate mouse and human models of craniosynostosis.
描述(申请人提供):颅缝早闭是人类的一个重要健康问题,但颅缝早闭的发病机制和机制仍未得到解决。临床和实验研究表明,转化生长因子-α 1(TGF-β 1)和成纤维细胞生长因子-2(FGF-2)参与颅缝融合。有证据表明,一种或两种分子对缝线融合的影响可能会被骨形态发生蛋白拮抗剂noggin进一步改变。在许多人类颅缝早闭综合征中已经报道了FGF受体的功能突变的获得,其中大多数这些综合征涉及FGF受体2(FGFR 2)。然而,TGF-β 1和FGF-2在颅缝发育中的确切作用尚未得到解释。我们假设:1)在小鼠后额叶(PF)缝发育期间,TGF-β 1和FGF-2的生物活性改变调节了上覆颅缝的融合; 2)这些分子在小鼠融合的PF缝中的表达与患有先天性颅缝早闭的人类儿童的融合缝中的表达相似。FGFR 2和noggin的改变也可能有助于改变TGF-β 1和FGF-2的生物活性,并进一步调节缝线融合。具体目的是1)定量从体内和体外模型中收获的小鼠颅骨组织中TGF-β 1、FGF-2、FGFR 2和noggin的基因表达。此外,将使用ELISA在体外培养基中测量TGF-β 1、FDF-2和头蛋白的蛋白水平。2)从先天性颅缝早闭患者中获取这些相同的生长因子和受体,定量分析其基因表达。我们将从接受开颅手术的儿童的融合缝线和专利缝线中采集组织,作为颅缝早闭标准治疗的一部分。这些数据将用于帮助确定小鼠和人类颅缝系统之间的关系。3)通过调节目标1中所述的生长因子和受体的生物利用度,在体外调节小鼠模型中的颅缝融合。我们将添加每种分子的重组形式或这些分子的抗体,以诱导正常开放的矢状缝融合或阻断PF缝的正常融合。4)探讨质粒DNA体外转染小鼠颅骨组织的可能性。如果成功的话,基因操纵的目标生长因子和受体可能会被用来调节颅缝的发展在未来的研究。5)获得足够的分子生物学知识,发展成为独立的临床科学家。这一建议将提供机制的见解颅缝发育的调节,并有助于将小鼠和人类模型的颅缝早闭。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TGF-beta1 RNA interference in mouse primary dura cell culture: downstream effects on TGF receptors, FGF-2, and FGF-R1 mRNA levels.
小鼠原代硬脑膜细胞培养中的 TGF-β1 RNA 干扰:对 TGF-β1 受体、FGF-2 和 FGF-R1 mRNA 水平的下游影响。
  • DOI:
    10.1097/prs.0b013e3181b98947
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Gosain,ArunK;Machol4th,JacquesA;Gliniak,Christy;Halligan,NadineLN
  • 通讯作者:
    Halligan,NadineLN
Detection of apoptosis in fusing versus nonfusing mouse cranial sutures.
融合与非融合小鼠颅缝中细胞凋亡的检测。
  • DOI:
    10.1097/01.scs.0000168759.61947.7f
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Agresti,Michael;Gosain,ArunK
  • 通讯作者:
    Gosain,ArunK
Real-time reverse transcriptase polymerase chain reaction: an improvement in detecting mRNA levels in mouse cranial tissue.
实时逆转录酶聚合酶链式反应:检测小鼠颅组织中 mRNA 水平的改进​​。
  • DOI:
    10.1097/01.prs.0000219339.82624.b9
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Singh,Rashmi;Recinos,RenéF;Agresti,Michael;Schaefer,RichardB;Bosbous,Mark;Gosain,ArunK
  • 通讯作者:
    Gosain,ArunK
Nonviral transfection of mouse calvarial organ in vitro using Accell-modified siRNA.
使用 Accell 修饰的 siRNA 对小鼠颅骨器官进行体外非病毒转染。
  • DOI:
    10.1097/prs.0b013e3181c82df1
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Gupta,AshimK;Eshraghi,Yashar;Gliniak,Christy;Gosain,ArunK
  • 通讯作者:
    Gosain,ArunK
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARUN K GOSAIN其他文献

ARUN K GOSAIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARUN K GOSAIN', 18)}}的其他基金

Determining the Biomechanical and Biological Response of Stretched Skin
确定拉伸皮肤的生物力学和生物反应
  • 批准号:
    9222011
  • 财政年份:
    2016
  • 资助金额:
    $ 13.19万
  • 项目类别:
Determining the Biomechanical and Biological Response of Stretched Skin
确定拉伸皮肤的生物力学和生物反应
  • 批准号:
    9112203
  • 财政年份:
    2016
  • 资助金额:
    $ 13.19万
  • 项目类别:
Regulation of Cranial Suture Development by TGF-B and FG
TGF-B 和 FG 对颅缝发育的调节
  • 批准号:
    6747314
  • 财政年份:
    2003
  • 资助金额:
    $ 13.19万
  • 项目类别:
Regulation of Cranial Suture Development by TGF and FGF
TGF 和 FGF 对颅缝发育的调节
  • 批准号:
    6579501
  • 财政年份:
    2003
  • 资助金额:
    $ 13.19万
  • 项目类别:
Regulation of Cranial Suture Development by TGF-B and FG
TGF-B 和 FG 对颅缝发育的调节
  • 批准号:
    6884840
  • 财政年份:
    2003
  • 资助金额:
    $ 13.19万
  • 项目类别:
Regulation of Cranial Suture Development by TGF-B and FG
TGF-B 和 FG 对颅缝发育的调节
  • 批准号:
    7304258
  • 财政年份:
    2003
  • 资助金额:
    $ 13.19万
  • 项目类别:
Regulation of Cranial Suture Development by TGF-B and FG
TGF-B 和 FG 对颅缝发育的调节
  • 批准号:
    7061252
  • 财政年份:
    2003
  • 资助金额:
    $ 13.19万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 13.19万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 13.19万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 13.19万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.19万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 13.19万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 13.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 13.19万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 13.19万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 13.19万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 13.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了